Correlation Between HTG Molecular and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HTG Molecular and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HTG Molecular and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HTG Molecular Diagnostics and Exagen Inc, you can compare the effects of market volatilities on HTG Molecular and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HTG Molecular with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of HTG Molecular and Exagen.

Diversification Opportunities for HTG Molecular and Exagen

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between HTG and Exagen is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding HTG Molecular Diagnostics and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and HTG Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HTG Molecular Diagnostics are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of HTG Molecular i.e., HTG Molecular and Exagen go up and down completely randomly.

Pair Corralation between HTG Molecular and Exagen

Given the investment horizon of 90 days HTG Molecular Diagnostics is expected to under-perform the Exagen. In addition to that, HTG Molecular is 2.87 times more volatile than Exagen Inc. It trades about -0.07 of its total potential returns per unit of risk. Exagen Inc is currently generating about 0.04 per unit of volatility. If you would invest  266.00  in Exagen Inc on September 3, 2024 and sell it today you would earn a total of  153.00  from holding Exagen Inc or generate 57.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy30.91%
ValuesDaily Returns

HTG Molecular Diagnostics  vs.  Exagen Inc

 Performance 
       Timeline  
HTG Molecular Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Exagen Inc 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

HTG Molecular and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HTG Molecular and Exagen

The main advantage of trading using opposite HTG Molecular and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HTG Molecular position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind HTG Molecular Diagnostics and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Valuation
Check real value of public entities based on technical and fundamental data